Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Colorectal Neoplasms × nilotinib × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Philadelphia Chromosome 2 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Leukemia, Myeloid, Chronic-Phase 2 Synovitis, Pigmented Villonodular 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 Leukemia 1 Giant Cell Tumor of Tendon Sheath 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Blast Crisis 1

Interventions

Bevacizumab 49 Fluorouracil 39 Cetuximab 39 Leucovorin 35 Oxaliplatin 34 pembrolizumab 33 Specimen Handling 27 Irinotecan 25 Biopsy 18 Magnetic Resonance Spectroscopy 16 regorafenib 15 Folfox protocol 15 Nivolumab 13 IFL protocol 13 Capecitabine 13 Standard of Care 12 Panitumumab 12 Carboplatin 11 HMPL-013 10 Cisplatin 10 trifluridine tipiracil drug combination 9 tislelizumab 9 Trifluridine 9 Gemcitabine 9 Blood Specimen Collection 9 atezolizumab 8 Methods 8 Educational Status 8 Early Intervention, Educational 8 Pemetrexed 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡